EPISODE · Apr 13, 2026 · 23 MIN
BIRSA101 and The Future Of Gene Therapy In India
from All Things Policy · host Takshashila Institution
November 2025 saw the launch of BIRSA 101- India’s first indigenous CRISPR-based gene therapy for sickle cell disease. What does this mean for affordable gene therapy, disease reduction and the research ecosystem in India? Shambhavi Naik explains some interesting aspects of this in this conversation with Suman Joshi.Check out Takshashila's brand-new offering - an Expert Capsule Course on the Politics and Policy of Critical Minerals. Early-bird applications close April 12th - school.takshashila.org.in/politics-and-policy-of-critical-mineralsAll Things Policy is a daily podcast on public policy brought to you by the Takshashila Institution, Bengaluru.Find out more on our research and other work here: https://takshashila.org.in/research-areasCheck out our public policy courses here: https://school.takshashila.org.in
What this episode covers
November 2025 saw the launch of BIRSA 101- India’s first indigenous CRISPR-based gene therapy for sickle cell disease. What does this mean for affordable gene therapy, disease reduction and the research ecosystem in India? Shambhavi Naik explains some interesting aspects of this in this conversation with Suman Joshi.Check out Takshashila's brand-new offering - an Expert Capsule Course on the Politics and Policy of Critical Minerals. Early-bird applications close April 12th - school.takshashila.org.in/politics-and-policy-of-critical-mineralsAll Things Policy is a daily podcast on public policy brought to you by the Takshashila Institution, Bengaluru.Find out more on our research and other work here: https://takshashila.org.in/research-areasCheck out our public policy courses here: https://school.takshashila.org.in
NOW PLAYING
BIRSA101 and The Future Of Gene Therapy In India
No transcript for this episode yet
Similar Episodes
Feb 4, 2026 ·18m
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m